Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982692priorityCriticalpatent/ECSP982692A/en
Publication of ECSP982692ApublicationCriticalpatent/ECSP982692A/en
La presente invención se refiere a un proceso para la preparación de un análogo de nucleósido de purina carbocíclica de la fórmula (I), sus sales y los derivados del mismo aceptables farmacéuticamente (gráfico).The present invention relates to a process for the preparation of a carbocyclic purine nucleoside analog of formula (I), its salts and pharmaceutically acceptable derivatives thereof (graph).
ECSP9826921998-10-101998-10-10
PROCESS FOR THE SYNTHESIS OF THE INTERMEDIATE COMPOUNDS OF CHLOROPURINE
ECSP982692A
(en)
VALACICLOVIR CHLORHYDRATE 2 - [(2-AMINO-1,6-DIHYDRO-6-OXO-9H-PURIN-9-IL) METOXI] ETHYL-L-VALINATE, USE TO PREPARE A MEDICINAL PRODUCT AND PROCESS TO OBTAIN SUCH CRYSTALLINE FORM
2-AMINO-7- (2-HYDROXYETHYL-1-SUBSTITUTED) -3,5-DIHYDROPYROL (3,2-D) PIRIMIDIN -4-ONAS, PHARMACEUTICAL COMPOSIONS AND THE USE OF THE SAME FOR THE MANUFACTURING OF A MEDICINAL PRODUCT.